Case Report of International Journal of Hospital Pharmacy
Total Quality Management Approach to Drug and Therapeutics Committee Guidelines in a Tertiary Care Government Hospital in Nepal
*Binaya Sapkota, BPharm, PharmD on behalf of Drug and Therapeutics Committee, Civil Service Hospital
Department of Pharmacy, Faculty of Health Sciences, Nobel College, Sinamangal, Kathmandu, Pokhara University
Background: Drug and Therapeutics Committee (DTC) is the principal policy making and recommending body for Civil Service Hospital (CSH). Condition of no functional DTC and guidelines based on the concept of total quality management (TQM) continuously presented inconsistencies health care delivery system at CSH. The present study was carried out at CSH from March 2012 to October 2015.
Objective: The present guidelines were targeted to the prescribers, pharmacists, and nurses for providing rational health care and disseminating uniform and state-of-art medicine information at CSH.
Methods: The present study was carried out at CSH from March 2012 to October 2015. The FOCUS-PDCA concept of TQM included following nine aspects: F: Find role of DTC for the improvement in the existing practice; O: Organize trained team knowledgeable of the process; C: Clarify operational definitions of DTC; U: Understand functions of DTC; S: Select rules and regulations for DTC members; P: Plan improvement procedures through the DTC meeting; D: Do improvement in DTC process; C: Check and analyze the results or outcomes obtained from the implementation of DTC guidelines; A: Act to explore the extent and scope of the guidelines.
Results: The present guidelines were developed based on the FOCUS-PDCA concept of TQM. DTC also developed quality assurance criteria, medicine information provision, pharmacovigilance center, pharmacoeconomic evaluation criteria and defined roles and responsibilities of the members.
Conclusions: DTC guidelines were developed at GoN CSH, based on FOCUS-PDCA model of TQM approach. The guidelines were based on rational pharmacotherapeutics concepts.
Keywords: Drug and Therapeutics Committee; guidelines; pharmacovigilance; FOCUS-PDCA; total quality management
How to cite this article:
Binaya Sapkota. Total Quality Management Approach to Drug and Therapeutics Committee Guidelines in a Tertiary Care Government Hospital in Nepal. International Journal of Hospital Pharmacy, 2017,2:1. DOI:10.28933/ijhp-2017-02-01 (This article was retracted from International Journal of Hospital Pharmacy on June 17, 2019 by following a request of the author . Please do not cite or use it for any purpose.)
1. Sapkota B, Gupta GK, Mainali D. Impact of intervention on healthcare waste management practices in a tertiary care governmental hospital of Nepal. BMC Public Health 2014; 14:1005. doi: 10.1186/1471-2458-14-1005.
2. Peer KS, Rakich JS. Accreditation and Continuous Quality Improvement in Athletic Training Education. Journal of Athletic Training 2000;35(2):188-193.
3. Holloway K, Green T. WHO. Drug and therapeutics committees: A practical guide. World Health Organization Department of Essential Drugs and Medicines Policy, Geneva, Switzerland, 2003:1-146.
4. ASHP. ASHP guidelines on the pharmacy and therapeutics committee and the formulary system. American Society of Health-System Pharmacists. Am J Health-Syst Pharm 2008; 65:1272–83.
5. Schachtner JM, Guharoy R, Medicis J, Newman N, and Speizer R. Prevalence and cost savings of therapeutic interchange among U.S. hospitals. Am J Hosp Pharm. 2002; 59:529-33.
6. Pillay T, Newby D, Walkom E. The role of pharmacoeconomics in formulary decision-making. Formulary. 2006;41:374–386.
7. Wood MJ, Bailey CJ. Making a case for inclusion of new oral antidiabetic agents in drug formularies. Pract Diab Int. 2000;17:141–146.
8. WHO. WHO Good manufacturing practices for pharmaceutical products: main principles. WHO Technical Report Series 2011;961 Annex 3:77-135.
9. WHO. WHO certification scheme on the quality of Pharmaceutical products moving in International commerce. World Health Organization Working document 2010 QAS/10.374:1-13.
10. Lehmann DF, Guharoy R, Page N, Hirschman K, Ploutz-Snyder R, Medicis J. Formulary management as a tool to improve medication use and gain physician support. Am J Health Syst Pharm 2007;64(5):464-6.
11. Alsultan MS. The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal 2011;19:51–56.